Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Sciwind Biosciences Announces Initiation of Patient Dosing in Phase 3 Clinical Trials of Ecnoglutide (XW003), a Long-acting GLP-1 analog, for the Treatment of Type 2 Diabetes in China 2023-01-31 08:00
Novotech Awarded by Frost & Sullivan for Global Biotech Clinical Trials Excellence in APAC 2023-01-31 05:37
Help Therapeutics Announces IND Approval of First Universal iPSC-derived Cardiomyocyte Therapy for End-stage Heart Failure in China 2023-01-30 23:00
Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDUTM (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer 2023-01-30 20:39
Duoning Headquarters in Fengxian Biotechnology Park with Centers for R&D and Technology Applications 2023-01-30 18:00
MGI Makes its Mark in Dubai with Latest Platforms at MEDLAB Middle East and Arab Health 2023-01-30 16:00
Kalbe Consumer Health Crowned Winner at the Asia Pacific Enterprise Awards 2022 Regional Edition 2023-01-30 11:26
Abbisko Therapeutics announces that US FDA has granted breakthrough therapy designation for its CSF-1R inhibitor Pimicotinib（ABSK021） 2023-01-30 11:00
Alpha Biopharma Submits New Drug Application for Zorifertinib, a Next-Generation EGFR-TKI to Treat EGFR-mutated NSCLC Patients with CNS Metastases 2023-01-30 10:00
SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs 2023-01-27 20:00
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results 2023-01-27 14:52
DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease 2023-01-27 08:46
Ascletis Announces IND Approval of Oral Viral Polymerase Inhibitor ASC10 for Monkeypox Indication by China NMPA 2023-01-26 21:08
ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Ambition to Become the Global Leader in Regenerative Therapies 2023-01-26 12:11
iNtRON has confirmed the efficacy of BAL200, a novel endolysin biologic for Inhalational Anthrax 2023-01-26 10:34
HBM Alpha Therapeutics Raises Seed Round to Advance Next-Gen Therapies for Endocrine Disorders 2023-01-26 09:22
GenKOre Announces Collaboration with a US-based Company on In vivo Gene-editing Therapy 2023-01-26 09:00
ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Ambition to Become the Global Leader in Regenerative Therapies 2023-01-26 08:11
PlumCare RWE partners with Lifebit on Greece's newborn genomic sequencing program, BeginNGS 2023-01-25 23:00
Singleron launches single cell eQTL analysis as part of their sequencing service 2023-01-25 19:00
1 128 129 130 131 132 452